Brisk walking can increase "good" HDL cholesterol and potentially lower "bad" LDL cholesterol. Learn how much (and how fast) ...

For those with diabetes aged 40 to 75 years of age, a moderate-intensity statin, defined as a drug that lowers LDL cholesterol 30% to 49%, should be used, whereas a high-intensity statin is a ...

STATIN THERAPY: High-Intensity Moderate-Intensity Low-Intensity; Daily dose lowers LDL-C by approx. ≥50% 10 • atorvastatin 40–80mg • rosuvastatin 20–40mg ...

The task force is now recommending a low- to moderate-intensity statin for 40- to 75-year-olds who might seem healthy but have a higher chance developing heart disease because of high blood ...

With the release of the 2013 ACC/AHA guidelines, prescribing of statin therapy, especially higher-intensity statin therapy for primary prevention of atherosclerotic CVD events, has been on the rise.

The American College of Cardiology and the American Heart Association just released new guidelines recommending that as many as 70 percent more Americans over age 45 should be taking statins. I have ...

The findings lend credence to the 2013 ACC/AHA guidelines' emphasis on starting with high-intensity statins in the highest-risk group, who have the most to gain from LDL lowering, the author says.

While high-intensity statin therapy is supported by guidelines for patients with atherosclerotic cardiovascular disease (ASCVD), many patients don’t end up being prescribed these medicines for reasons ...

Critics of the guidelines say that most people who take statins for primary prevention – meaning, to prevent a first stroke or heart attack – don’t actually benefit from it, but they could ...

National guidelines recommend high-intensity statin therapy after a CHD-related hospitalization, but most Medicare beneficiaries hospitalized for CHD events did not fill prescriptions for high ...

In patients with atherosclerotic cardiovascular disease, study authors from Stanford University found that those who received high-intensity statins had the biggest reduction in mortality risk.

Although medical guidelines recommend high-intensity statins for nearly all people with established cardiovascular disease, previous studies have shown that rates of guideline compliance are low.